Á. G. Zotano

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

A. González-Angulo, G. Catalán, J. G. Saenz, 2014, Breast Cancer Research and Treatment.

Patterns of death among patients treated at a Department of Medical Oncology in Spain

J. M. Saera, J. A. Urtasun, R. D. Beveridge, 2004 .

High risk Ewing's sarcomas. Effectiveness and toxicity of a regimen designed for children and used in adults

J. Pérez-Fidalgo, J. M. Salcedo, Á. S. Huerta, 2004 .

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

M. Buyse, N. Robert, M. Gnant, 2016, The Lancet. Oncology.

Breast cancer in pregnancy: an institutional experience

A. R. Simón, V. Porta, J. G. Gregori, 2015, Ecancermedicalscience.

A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.

F. Cardoso, M. Aapro, V. Tjan-Heijnen, 2013, Cancer treatment reviews.

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.

M. Buyse, M. Gnant, H. Iwata, 2023, European journal of cancer.